Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
09. Januar 2025 05:00 ET
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08. Januar 2025 21:00 ET
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
プリモ (Primo)、シャイン (SHINE) と提携し、アジア太平洋地域で精密がん治療を前進へ
08. Januar 2025 20:00 ET
|
Primo Biotechnology Co., Ltd.
台北 (台湾) 発 , Jan. 09, 2025 (GLOBE NEWSWIRE) -- プリモ・バイオテクノロジー (Primo Biotechnology、以下「プリモ」) は、核医学製造の世界的リーダーであるシャイン・テクノロジーズ (SHINE Technologies、以下「シャイン」) との戦略的提携を発表した。 この契約により、プリモはIlumira™...
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08. Januar 2025 20:00 ET
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
08. Januar 2025 10:00 ET
|
Primo Biotechnology Co., Ltd.
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.